EC
LOXO

EcoR1 Capital’s Loxo Oncology, Inc LOXO Stock Holding History

EcoR1 Capital’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-150,308
Closed -$4.11M – 42
2016
Q1 		$4.11M Buy
+150,308
New +$3.15M 1.44% 23

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EcoR1 Capital's LOXO Position: Q2 2016 in Review

EcoR1 Capital sold out of Loxo Oncology, Inc (LOXO) in Q2 2016, closing a stake of 150,308 shares — an estimated $4.11M sold.

EcoR1 Capital first reported a position in LOXO in Q1 2016 and held it in 1 quarter. The position peaked at $4.11M in Q1 2016. 73 funds tracked by Wall St. Rank hold LOXO as of Q2 2016.

  • EcoR1 Capital reported no remaining Loxo Oncology, Inc position as of Q2 2016 after selling out during the quarter.
  • EcoR1 Capital sold 150,308 Loxo Oncology, Inc shares in Q2 2016, an estimated $4.11M.
  • EcoR1 Capital first reported a position in Loxo Oncology, Inc in Q1 2016 and held it in 1 quarter.
  • EcoR1 Capital's Loxo Oncology, Inc position peaked at $4.11M in Q1 2016.
  • 73 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q2 2016.

Based on EcoR1 Capital's 13F filing for Q2 2016, filed 15 Aug 2016.